Abecma

2seventy Bio stops enrolling patients in blood cancer therapy study
Reuters
Wed, 09/25/24 - 11:56 am
2seventy bio
Bristol Myers Squibb
Multiple Myeloma
cell therapy
Abecma
clinical trials
3 Big Pharma cancer drugs facing inflation penalties
Pharma Voice
Wed, 07/31/24 - 10:27 am
inflation
Inflation Reduction Act
drug pricing
Abecma
Breyanzi
Bristol Myers Squibb
Pfizer
Adcetris
Astellas
Padcev
cancer
FDA allows expanded use of Bristol Myers' cell therapy for blood cancer
Reuters
Fri, 04/5/24 - 11:40 am
Bristol Myers Squibb
2seventybio
Abecma
cell therapy
Despite early death concerns, FDA advisers back J&J and Legend's Carvykti and BMS' Abecma for earlier myeloma
Fierce Pharma
Sun, 03/17/24 - 09:30 pm
JNJ
Legend Biotech
CAR-T
FDA
Carvykti
Abecma
FDA Adcomm to Tackle Complexity of CAR-T for Multiple Myeloma
BioSpace
Mon, 03/11/24 - 11:53 am
CAR-T
Multiple Myeloma
FDA
Bristol Myers Squibb
2seventy bio
Abecma
JNJ
Legend Biotech
Carvykti
FDA sets date for high-profile CAR-T adcomm for Bristol's Abecma, J&J's Carvykti
Fierce Pharma
Sun, 02/4/24 - 12:39 pm
Bristol Myers Squibb
Abecma
FRDA
CAR-T
JNJ
Carvykti
2seventy bio to sell experimental cell therapies, names new CEO
Reuters
Tue, 01/30/24 - 10:23 am
2seventy bio
Regeneron
Abecma
cell therapy
ASH: Abecma’s survival data show why FDA wanted expert meeting on the Bristol Myers cell therapy
Fierce Pharma
Mon, 12/11/23 - 10:55 pm
ASH 2023
Abecma
FDA
CAR-T
Bristol Myers Squibb
FDA to delay decision on Bristol Myers-2seventy bio cancer therapy
Reuters
Mon, 11/20/23 - 10:12 am
Bristol Myers Squibb
2seventy bio
blood cancer
FDA
Abecma
5 FDA decisions to watch in the fourth quarter
BioPharma Dive
Mon, 10/2/23 - 12:00 pm
FDA
Alnylam
Onpattro
ATTR amyloidosis
Vertex Pharmaceuticals
CRISPR Therapeutics
exa-cel
Bluebird Bio
Zynteglo
sickle cell disease
Bristol Myers Squibb
2seventy bio
Abecma
Multiple Myeloma
Amgen
Lumakras
non-small cell lung cancer
Pfizer
estrasimod
ulcerative colitis
J&J, Legend's Carvykti cut risk of progression or death by whopping 74% in earlier myeloma, leaked abstract shows
Fierce Pharma
Wed, 04/19/23 - 11:24 am
CAR-T
Bristol Myers Squibb
JNJ
Legend Biotech
AACR
Multiple Myeloma
Carvykti
Abecma
Bristol Myers details landmark Abecma multiple myeloma data that ASH turned down
Fierce Pharma
Sun, 02/12/23 - 07:46 pm
Bristol Myers Squibb
Abecma
CAR-T
Multiple Myeloma
ASH: Bristol's 3rd-line Abecma data didn't make the trip to New Orleans. Is it cause for concern?
Fierce Pharma
Mon, 12/12/22 - 10:59 pm
Bristol Myers Squibb
ASH 2022
Abecma
clinical trials
Multiple Myeloma
Even as Revlimid's star fades, Bristol Myers' core offerings have reached a 'critical mass,' CEO says
Fierce Pharma
Thu, 10/27/22 - 11:04 am
Bristol Myers Squibb
generics
Revlimid
Abecma
Breyanzi
Pharma CEOs
Giovanni Caforio
Bristol Myers claims success in study testing earlier CAR-T use in multiple myeloma
BioPharma Dive
Wed, 08/10/22 - 11:34 pm
Bristol Myers Squibb
2seventy bio
Abecma
CAR-T
Multiple Myeloma
Bristol's Abecma, Amgen's Lumakras headline record-setting oncology launch class as costs continue to balloon: IQVIA
Fierce Pharma
Thu, 05/26/22 - 10:53 pm
oncology
cancer
IQVIA
Bristol Myers Squibb
Abecma
Amgen
Lumakras
Bristol busy boosting supply of Breyanzi, Abecma as massive Revlimid patent cliff looms
Fierce Pharma
Fri, 02/4/22 - 11:22 am
Bristol Myers Squibb
CAR-T
Breyanzi
Abecma
As Abecma sales take off, Bristol Myers and 2seventy scrap a follow-up CAR-T
Endpoints
Thu, 01/13/22 - 07:21 am
Bristol Myers Squibb
2seventy bio
Abecma
bb21217
CAR-T
Bristol Myers sees automation, virtual reality on the horizon for pair of new CAR-T manufacturing plants
Fierce Pharma
Mon, 05/3/21 - 11:11 am
Bristol Myers Squibb
CAR-T
drug manufacturing
Breyanzi
Abecma
Bristol Myers, bluebird bio have their BCMA CAR-T nod, but latecomer J&J could have an advantage: analysts
Fierce Pharma
Mon, 03/29/21 - 10:55 pm
Bristol Myers Squibb
Bluebird Bio
CAR-T
JNJ
Legend Biotech
Abecma

Pages